Microsoft Launches Project Quine, an Experimental AI System Aimed at Speeding Up Drug Discovery

September 30 (IT Home) — On the 29th local time, Microsoft Research introduced Project Quine, an experimental multimodal AI research system. Project Quine is described as a “world model” for biological research, with the goal of connecting computational biology modelling with actual wet-lab experiments.

Project Quine was developed by Microsoft Research together with Harvard University and the Broad Institute of MIT and Harvard. The system combines a joint representation world model covering genomics, proteins, chemistry, cell states and biological imaging with an interactive reasoning framework. To let researchers use Project Quine as early as possible, Microsoft has opened applications for the first Quine Fellows programme. In the future, Microsoft plans to widen commercial access gradually through products such as Microsoft Discovery.

Project Quine is not limited to a single field of research; it can process information from the areas above at the same time, allowing comprehensive cross-model analysis. With this architecture, some bottlenecks in traditional drug discovery could be broken: researchers can first pre-screen candidate compounds and rank them by priority using computational methods, and then put limited laboratory resources into the candidates most worth validating.

Microsoft also stressed that although Project Quine is highly promising, it is currently limited to scientific research and is not intended for clinical use. Any results researchers obtain with the system must also go through rigorous human evaluation to confirm whether they are correct, because AI still makes mistakes.

Microsoft recently used Project Quine to test pancreatic ductal adenocarcinoma cell lines. In just one weekend, the system prioritised compounds expected to push the cell state from the classical type towards the basal-like type, and also uncovered some unexpected phenotypic responses.

According to IT Home’s understanding, researchers who want early access to Project Quine can apply directly to the newly launched Quine Fellows programme. As the technology gradually moves out of the research stage, Microsoft will widen access through Microsoft Discovery and release more commercial tools in turn.

The system is expected to greatly shorten the time needed for drug discovery, saving years of work and millions of dollars, and may also help researchers find treatment paths they had not previously anticipated.